LifeVantage Corporation, Maker of Protandim(R), Joins Forces with Cornerstone R&D, Inc. to Dramatically Cut Manufacturing Costs
LifeVantage Corporation(OTCBB:LFVN), the maker of Protandim®, the only product clinically proven to slow the progressive rate of aging, announced the company has joined forces with Cornerstone Research and Development, Inc., a leading manufacturer owned by Mitsui USA, to dramatically cut product manufacturing costs.
David Brown, LifeVantage President and CEO, said, "By utilizing Cornerstone's manufacturing efficiencies, we are able to significantly lower our costs of manufacturing Protandim. The net result will be an approximate 50 percent decrease in manufacturing costs."
Additionally, David Brown commented, "The formation of a partnership with Cornerstone is an exciting development for LifeVantage. Cornerstone's industry-leading Good Manufacturing Practices (GMP) will allow us to not only save money, but maintain the high quality standards for which Protandim® is known. Cornerstone's GMP certifications will now allow us to pursue endorsement opportunities involving professional athletes and teams, as well as more easily achieve product registration in Canada and in other countries that have previously been unavailable to us."
About Cornerstone Research and Development, Inc.
Cornerstone Research and Development, Inc. formulates and manufactures hundreds of dietary supplement products, including single herb and herbal formulas, vitamins, mineral, homeopathy, and specialty formulas. Based in Utah, the manufacturing company uses cutting-edge capabilities to specialize in research, packaging, and developing supplement products. For more information, please visit www.cornerstonerdi.com.
Protandim® is a groundbreaking, clinically proven solution for healthy aging. This patented anti-oxidant therapy is 1000's of times more powerful than red wine, oranges, blueberries, acai juice or other popular anti-oxidant supplements. Protandim works by increasing the body's natural anti-oxidant protection at the cellular level, triggering cells to produce naturally occurring protective antioxidant enzymes such as super oxide dismutase (SOD), catalase, and glutathione. A peer-reviewed scientific study shows that after 30 days of taking Protandim, free radicals decreased an average of 40 percent, slowing the progressive aging factors to the level of a 20 year old. Protandim is currently the subject of over 20 scientific studies at leading universities and research institutes. For more information, please visit the Protandim® product web site at www.protandim.com or contact Jan Strode at (619) 890-4040.
LifeVantage Corporation is a publicly traded (OTCBB:LFVN), science based, natural products company, dedicated to helping people reach their health and wellness goals through science-based solutions to oxidative stress. Founded in 2003 and based in Colorado, LifeVantage develops nutraceutical products, including Protandim, that leverage the company's expertise and that are intended to deliver significant health benefits to consumers. For more information, visit www.lifevantage.com or contact Jan Strode at (619) 890-4040.
This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.The Company uses the words "anticipate,""believe,""could,""should,""estimate,""expect,""intend,""may,""predict,""project,""plan,""target" and similar terms and phrases, including references to assumptions, to identify forward-looking statements.These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein.These risks and uncertainties include, among others, the risk that government regulators and regulations could adversely affect our business; future laws or regulations may hinder or prohibit the production or sale of our existing product and any future products; unfavorable publicity could materially hurt our business; and the Company's ability to protect our intellectual property rights and the value of our product.These and other risk factors are discussed in greater detail in the Company's Annual Report on Form 10-KSB under the caption "Risk Factors," and in other documents filed the Company from time to time with the Securities and Exchange Commission.The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document.All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law.
* These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
Note to Editors: Contact Jan Strode at 619-890-4040 for interviews, photography, and other requests.
LifeVantage Corporation
Jan Strode, 619-890-4040